R. Tang

1.6k total citations · 2 hit papers
14 papers, 1.1k citations indexed

About

R. Tang is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, R. Tang has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in R. Tang's work include Genetic factors in colorectal cancer (5 papers), RNA modifications and cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). R. Tang is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), RNA modifications and cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). R. Tang collaborates with scholars based in Taiwan, United States and Germany. R. Tang's co-authors include Tariq M. Rana, Na Li, Hui Hui, Yuqi Kang, Kriti Agrawal, Lingling Wang, Sarah Huff, Sandip Pravin Patel, Jiajun Yuan and Yinsheng Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Scientific Reports.

In The Last Decade

R. Tang

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

2020 427 citations Na Li, Yuqi Kang et al. Proceedings of the National Academy of Sciences profile →
m ⁶ A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy

2020 311 citations Lingling Wang, Hui Hui et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Tang Taiwan	12	752	468	345	141	126	14	1.1k
Ruiyan Wu China	10	817 1.1×	437 0.9×	210 0.6×	38 0.3×	96 0.8×	24	1.0k
Dongjian Ji China	17	848 1.1×	606 1.3×	191 0.6×	93 0.7×	47 0.4×	28	1.0k
Zizhen Zhang China	7	501 0.7×	311 0.7×	147 0.4×	23 0.2×	49 0.4×	12	733
Cuijuan Zhang China	18	790 1.1×	527 1.1×	218 0.6×	85 0.6×	89 0.7×	39	1.1k
Guohui Qin China	19	542 0.7×	322 0.7×	466 1.4×	26 0.2×	112 0.9×	35	1.1k
Ming Quan China	18	584 0.8×	264 0.6×	200 0.6×	56 0.4×	79 0.6×	37	799
Cecilia Monge United States	8	355 0.5×	220 0.5×	393 1.1×	60 0.4×	78 0.6×	30	745
Mengnuo Chen Hong Kong	6	1.4k 1.8×	824 1.8×	130 0.4×	24 0.2×	52 0.4×	6	1.5k
Sihao Huang China	16	626 0.8×	447 1.0×	172 0.5×	37 0.3×	40 0.3×	25	896

Countries citing papers authored by R. Tang

Since Specialization

Citations

This map shows the geographic impact of R. Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Tang more than expected).

Fields of papers citing papers by R. Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Tang. The network helps show where R. Tang may publish in the future.

Co-authorship network of co-authors of R. Tang

This figure shows the co-authorship network connecting the top 25 collaborators of R. Tang. A scholar is included among the top collaborators of R. Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Tang. R. Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tang, R., Kwamina Nyame, Nouf N. Laqtom, et al.. (2024). TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Scientific Reports. 14(1). 17469–17469. 5 indexed citations

Li, Na, Yufei Deng, R. Tang, et al.. (2023). KIAA1429 / VIRMA promotes breast cancer progression by m ⁶ A ‐dependent cytosolic HAS2 stabilization. EMBO Reports. 24(10). e55506–e55506. 14 indexed citations

Wang, Lingling, Hui Hui, Kriti Agrawal, et al.. (2020). m ⁶ A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy. The EMBO Journal. 39(20). e104514–e104514. 311 indexed citations breakdown →

Rosato, Anna Scotto, R. Tang, & Christian Grimm. (2020). Two-pore and TRPML cation channels: Regulators of phagocytosis, autophagy and lysosomal exocytosis. Pharmacology & Therapeutics. 220. 107713–107713. 42 indexed citations

Grimm, Christian & R. Tang. (2020). Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?. Cell Calcium. 88. 102212–102212. 27 indexed citations

Li, Na, Yuqi Kang, Lingling Wang, et al.. (2020). ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proceedings of the National Academy of Sciences. 117(33). 20159–20170. 427 indexed citations breakdown →

Yeh, Kun‐Yun, Ling‐Ling Hsieh, Cheng Lü, et al.. (2010). Analysis of the Effect of Serum Interleukin-6 (IL-6) and Soluble IL-6 Receptor Levels on Survival of Patients with Colorectal Cancer. Japanese Journal of Clinical Oncology. 40(6). 580–587. 40 indexed citations

Chiang, Jy‐Ming, et al.. (2010). Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. International Journal of Colorectal Disease. 25(8). 941–947. 31 indexed citations

Tang, R., et al.. (2009). Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene. Clinical Genetics. 75(4). 334–345. 23 indexed citations

10.

Chiang, Jy‐Ming, et al.. (2009). Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families. Familial Cancer. 9(2). 117–124. 12 indexed citations

11.

Chiang, Jy‐Ming, et al.. (2007). Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan. British journal of surgery. 95(1). 102–110. 12 indexed citations

12.

Tang, R.. (2003). Colorectal cancer without high microsatellite instability and chromosomal instability--an alternative genetic pathway to human colorectal cancer. Carcinogenesis. 25(5). 841–846. 67 indexed citations

13.

Tang, R., et al.. (1995). Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum.. PubMed. 180(6). 705–12. 89 indexed citations

14.

Tang, R., et al.. (1990). Perianal Paget's disease--report of 4 cases.. PubMed. 13(4). 314–21. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact